130 related articles for article (PubMed ID: 29225856)
1. Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient.
Kerkhoff AD; Patrick L; Cornett P; Kleinhenz ME; Brondfield S
Clin Case Rep; 2017 Dec; 5(12):2059-2061. PubMed ID: 29225856
[TBL] [Abstract][Full Text] [Related]
2. Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Bandara M; Seder DB; Garratty G; Leger RM; Zuckerman JB
Case Rep Med; 2010; 2010():161454. PubMed ID: 20589083
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
[TBL] [Abstract][Full Text] [Related]
4. Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
Roehmel J; Specht P; Staab D; Schwarz C; Salama A; Mayer B
Transfusion; 2019 Dec; 59(12):3746-3754. PubMed ID: 31724753
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
Meinus C; Schwarz C; Mayer B; Roehmel JF
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797815
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic anemia as a result of piperacillin/tazobactam administration: a case report and discussion of pathophysiology.
Zanetti RC; Biswas AK
Mil Med; 2013 Sep; 178(9):e1045-7. PubMed ID: 24005557
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Kunzmann S; Thomas W; Mayer B; Kuhn S; Hebestreit H
Infection; 2010 Apr; 38(2):131-4. PubMed ID: 20213286
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient.
Chavez A; Mian A; Scurlock AM; Blackall D; Com G
J Cyst Fibros; 2010 Dec; 9(6):433-8. PubMed ID: 20833594
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
LeCleir LK; Pettit RS
Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
Butterfield JM; Lodise TP; Beegle S; Rosen J; Farkas J; Pai MP
J Antimicrob Chemother; 2014 Jan; 69(1):176-9. PubMed ID: 23869050
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
[TBL] [Abstract][Full Text] [Related]
12. The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review.
Salim H; Musmar B; A Sarhan FM; Giacaman N; Abu Omar S
Cureus; 2023 Mar; 15(3):e35915. PubMed ID: 37038577
[TBL] [Abstract][Full Text] [Related]
13. Immune hemolytic anemia caused by drugs.
Garratty G
Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
[TBL] [Abstract][Full Text] [Related]
14. Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?
Crass RL; Pai MP; Lodise TP
J Antimicrob Chemother; 2019 Jan; 74(1):126-129. PubMed ID: 30252050
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin-induced immune hemolysis presenting with tachycardia and cardiac arrest.
Lohiya GS; Tan-Figueroa L; Krishna V
Case Rep Med; 2011; 2011():816497. PubMed ID: 22235207
[TBL] [Abstract][Full Text] [Related]
16. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic anaemia caused by piperacillin-tazobactam.
Dapper I; Nauwynck M; Selleslag D; Hidajat M; Bourgeois M; Martens P; Wilmer A
Acta Clin Belg; 2009; 64(6):517-9. PubMed ID: 20101875
[TBL] [Abstract][Full Text] [Related]
18. Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.
Swe T; Ali M; Naing AT
BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440850
[TBL] [Abstract][Full Text] [Related]
19. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
[TBL] [Abstract][Full Text] [Related]
20. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.
Mayer B; Yürek S; Salama A
Transfusion; 2010 May; 50(5):1135-8. PubMed ID: 20051057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
